Latest / Stock Movers / Novo Nordisk Slump, SocGen's 'Easy Wins', Berentzen Grupp Deal
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios. Podcasts. Radio. News. The Stock Movers Report.
- 0:10Speaker 1: Your roundup of companies making moves in the stock market.
- 0:13Speaker 1: Harnessing the power of Bloomberg data.
- 0:16Speaker 2: Now, let's look at some of the stocks on the
- 0:18Speaker 2: move today here in Europe. I'm Caroline Hepka with Lizzie Burton,
- 0:21Speaker 2: and we're joined by Bloomberg's breaking news editor, Louise Moon. So,
- 0:25Speaker 2: let's get into the detail of Nova Nordisk unveiling their
- 0:28Speaker 2: future plans. Is it a shot in the arm?
- 0:30Speaker 1: They might need it.
- 0:31Speaker 2: They've got a lot of competition.
- 0:33Speaker 1: Out there now.
- 0:33Speaker 3: Been falling behind Eli Lilly, despite being the first one
- 0:36Speaker 3: to have a blockbuster medicine within the obesity space. And so,
- 0:42Speaker 3: this Capital Markets Day was all about showing investors how
- 0:44Speaker 3: they can start to compete in that race and move ahead.
- 0:49Speaker 3: But it's failed to impress. So, they pledged to launch
- 0:53Speaker 3: more than five blockbuster drugs. And they also pledged to
- 0:57Speaker 3: deliver more than $ 23 billion in new sales in the
- 1:00Speaker 3: coming years. And then they've also said that they'll explore
- 1:03Speaker 3: takeovers alongside that pipeline of drugs. Shares fallen almost 8%
- 1:09Speaker 3: after that. As I say, investors are disappointed. They were
- 1:12Speaker 3: hoping for more concrete turnaround plans for Novo. Analysts are
- 1:16Speaker 3: saying that it lacked detail on how exactly it's going
- 1:19Speaker 3: to boost growth and deliver on all those pledges. As
- 1:24Speaker 3: I say, they've already fallen behind Eli Lilly. They've also
- 1:27Speaker 3: more recently had a series of clinical trial disappointments. And so,
- 1:32Speaker 3: this wasn't really enough to convince investors going forward. The
- 1:36Speaker 3: CEO saying, you know, we need to work harder and
- 1:38Speaker 3: we will. And shares showing that that is very much needed.
- 1:43Speaker 1: Okay.
- 1:43Speaker 2: Well, let's turn to a positive story, shall we? We're
- 1:45Speaker 2: looking at SockGen shares up 2.9% at 9.56 a.m.
- 1:50Speaker 1: Why?
- 1:51Speaker 3: So, they've lifted profitability targets. So, their return on tangible equity,
- 1:58Speaker 3: for comparison purposes, that's around 11% their target for 2026.
- 2:03Speaker 3: They've then said that they're now targeting up to 14%
- 2:05Speaker 3: for 2029 and more than 15% for after that. On
- 2:11Speaker 3: top of that, they've also pledged more cost cuts. That's
- 2:14Speaker 3: thought to be from more headcount reduction, a decrease in
- 2:18Speaker 3: IT spending, among other spending as well. They're also aiming
- 2:21Speaker 3: to give shareholders at least € 21 billion for all the
- 2:25Speaker 3: years through 2029. And as you say, shares rising on
- 2:28Speaker 3: the back of this. It's all the CEO's new strategy,
- 2:31Speaker 3: a new phase of his strategy to accelerate growth, maintain costs,
- 2:37Speaker 3: boost investor payouts. He's already been doing a lot of this.
- 2:40Speaker 3: He's shaken up quite a lot of top management positions.
- 2:42Speaker 3: He's ended the policy to work from home. He's already
- 2:45Speaker 3: cut a lot of jobs and that's already helped to
- 2:47Speaker 3: boost the share price. And this is kind of the
- 2:49Speaker 3: next phase coming through lifting those profitability targets and boosting
- 2:53Speaker 3: shares in morning trading.
- 2:54Speaker 2: Yeah. And then lastly, breaking out this Berenzi group. um
- 3:04Speaker 2: story tell us a little bit about this is it
- 3:05Speaker 2: about schnapps i'm sorry i hesitated and now i'm like
- 3:09Speaker 2: is this story about alcohol.
- 3:11Speaker 3: It is it is so it's another alcohol um deal
- 3:14Speaker 3: which is quite interesting because there's been a couple recently
- 3:16Speaker 3: so the u.s spirits firm called uh sazarac plans to
- 3:21Speaker 3: buy okay now that i've heard of yes so they're
- 3:24Speaker 3: planning to buy that this german maker of schnapps which
- 3:26Speaker 3: obviously um very well known uh this is part of
- 3:30Speaker 3: sazarac's plan to expand into europe and expand more broadly
- 3:33Speaker 3: they recently bought a uk brand called alvoca um so
- 3:37Speaker 3: that's another deal that's been happening in that space recently
- 3:40Speaker 3: um really boosting this german company shares the shares rose
- 3:45Speaker 3: 22 giving it a market cap of about 53 million
- 3:48Speaker 3: euros so it's not a huge huge company but it's
- 3:50Speaker 3: another interesting deal within that space um and all on
- 3:53Speaker 3: the back of this this changing of demand uh within.
- 3:56Speaker 1: The alcohol industry The Stock Movers Report from Bloomberg Radio.
- 4:01Speaker 1: Check back with us throughout the day for the latest
- 4:04Speaker 1: roundup of companies making news on Wall Street. And for
- 4:07Speaker 1: the latest market-moving headlines, listen to Bloomberg Radio Live. Catch
- 4:12Speaker 1: us on YouTube, Bloomberg.com, and on Apple CarPlay and Android
- 4:16Speaker 1: Auto with the Bloomberg Business app.